◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 0673

China Health Group Limited (0673) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Distribution · DATA UPDATED 2026-08-10

China Health Group Limited (0673) operates in the Medical Distribution industry and is headquartered in Central, Hong Kong with about 111 employees. Its market capitalization is roughly HKD 485 million. In the fiscal year ended 2025-03-31, 0673 reported HKD 39M in revenue and (HKD 68M) in net income.

China Health Group Limited, an investment holding company, engages in the distribution and services of medical equipment and consumables in the People's Republic of China.

Interactive charts & full statements →

0673 Revenue & Earnings History — Annual Income Statement

Income statement2025-03-312024-03-312023-03-312022-03-31
Total RevenueHKD 39MHKD 60MHKD 76MHKD 107M
Gross ProfitHKD 9MHKD 14MHKD 27MHKD 29M
Operating Income (EBIT)(HKD 60M)(HKD 38M)(HKD 12M)(HKD 12M)
Net Income(HKD 68M)(HKD 40M)(HKD 42M)(HKD 12M)

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0673 Free Cash Flow History

0673 Balance Sheet History

Balance sheet2025-03-312024-03-312023-03-312022-03-31
Total AssetsHKD 147MHKD 192MHKD 221MHKD 226M
Total LiabilitiesHKD 147MHKD 133MHKD 127MHKD 141M

HKD; HKDM / HKDB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0673 viewer.

Other Companies in Medical Distribution

← 0672All “0-9” companies0674 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.